Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular”

594 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 594 results

Large-scale testing (Phase 3)Ended earlyNCT01944839
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 619
Not applicableUnknownNCT01608113
What this trial is testing

Long-term Follow-up of Subfoveal Neovascular AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Medical University of Vienna 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT05230537
What this trial is testing

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 168
Large-scale testing (Phase 3)Study completedNCT04777201
What this trial is testing

Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Hoffmann-La Roche 1,036
Early research (Phase 1)UnknownNCT00767949
What this trial is testing

Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Lpath, Inc. 15
Large-scale testing (Phase 3)Study completedNCT00967850
What this trial is testing

Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia

Who this might be right for
MyopiaChoroidal Neovascularization
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 56
Testing effectiveness (Phase 2)Study completedNCT05456828
What this trial is testing

ASKG712 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Visara, Inc. 56
Testing effectiveness (Phase 2)Ended earlyNCT00414206
What this trial is testing

Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
CoMentis 343
Large-scale testing (Phase 3)Study completedNCT05161806
What this trial is testing

Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Sandoz 30
Not applicableStudy completedNCT04662944
What this trial is testing

A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 494
Testing effectiveness (Phase 2)Ended earlyNCT00857259
What this trial is testing

The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Choroidal Neo-Vascular Age-onset Macular DegenerationAge-related Macular Degeneration
Novartis Pharmaceuticals 16
Not applicableActive Not RecruitingNCT07390253
What this trial is testing

Switch From 2mg Aflibercept to 8mg Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Vienna Institute for Research in Ocular Surgery 50
Not applicableStudy completedNCT02194803
What this trial is testing

Observation of Treatment Patterns With Lucentis in Approved Indications

Who this might be right for
Neovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV
Novartis Pharmaceuticals 5,778
Not applicableStudy completedNCT01883856
What this trial is testing

Comparison of Silicone and Porous Plate Ahmed Glaucoma Valves

Who this might be right for
Glaucoma
Peter Netland, MD 52
Large-scale testing (Phase 3)Active Not RecruitingNCT05112861
What this trial is testing

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders

Who this might be right for
Age-Related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration+2 more
Outlook Therapeutics, Inc. 120
Large-scale testing (Phase 3)Study completedNCT00531024
What this trial is testing

Systemic Avastin Therapy in Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 30
Not applicableStudy completedNCT01773954
What this trial is testing

Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationMacular Degeneration
MidAtlantic Retina 40
Early research (Phase 1)Not Yet RecruitingNCT05611424
What this trial is testing

Gene Therapy for Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Frontera Therapeutics 18
Not applicableStudy completedNCT05969418
What this trial is testing

Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC

Who this might be right for
Macular Degeneration Choroidal Neovascularization
Federico II University 50
Early research (Phase 1)Study completedNCT00782093
What this trial is testing

Ascending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 63
Next Page